813 related articles for article (PubMed ID: 32588725)
1. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
[TBL] [Abstract][Full Text] [Related]
2. Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease.
Raj AS; Shanahan ER; Tran CD; Bhat P; Fletcher LM; Vesey DA; Morrison M; Holtmann G; Macdonald GA
Clin Transl Gastroenterol; 2019 Aug; 10(8):e00068. PubMed ID: 31373933
[TBL] [Abstract][Full Text] [Related]
3. Alcohol or Gut Microbiota: Who Is the Guilty?
Meroni M; Longo M; Dongiovanni P
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
[TBL] [Abstract][Full Text] [Related]
4. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
[TBL] [Abstract][Full Text] [Related]
5. Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol-associated liver disease in humans.
Maccioni L; Loriot A; Dewulf J; Bommer G; Horsmans Y; Lanthier N; Leclercq I; Schnabl B; Stärkel P
Aliment Pharmacol Ther; 2022 Sep; 56(6):1055-1070. PubMed ID: 35919965
[TBL] [Abstract][Full Text] [Related]
6. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
[TBL] [Abstract][Full Text] [Related]
7. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
8. Change of the duodenal mucosa-associated microbiota is related to intestinal metaplasia.
Gong J; Li L; Zuo X; Li Y
BMC Microbiol; 2019 Dec; 19(1):275. PubMed ID: 31815623
[TBL] [Abstract][Full Text] [Related]
9. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis.
Lin R; Zhou L; Zhang J; Wang B
Int J Clin Exp Pathol; 2015; 8(5):5153-60. PubMed ID: 26191211
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model.
Yu L; Wang L; Yi H; Wu X
Gut Microbes; 2020 Jul; 11(4):1015-1029. PubMed ID: 32167008
[TBL] [Abstract][Full Text] [Related]
11. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
Leclercq S; de Timary P; Stärkel P
Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
[TBL] [Abstract][Full Text] [Related]
12. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease.
Maccioni L; Leclercq IA; Schnabl B; Stärkel P
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884492
[TBL] [Abstract][Full Text] [Related]
13. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
[TBL] [Abstract][Full Text] [Related]
14. The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage.
Plaza-Díaz J; Solís-Urra P; Rodríguez-Rodríguez F; Olivares-Arancibia J; Navarro-Oliveros M; Abadía-Molina F; Álvarez-Mercado AI
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171747
[TBL] [Abstract][Full Text] [Related]
15. MUP1 mediates urolithin A alleviation of chronic alcohol-related liver disease via gut-microbiota-liver axis.
Zhang H; Li C; Han L; Xiao Y; Bian J; Liu C; Gong L; Liu Z; Wang M
Gut Microbes; 2024; 16(1):2367342. PubMed ID: 38889450
[TBL] [Abstract][Full Text] [Related]
16. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
Li F; Wang M; Wang J; Li R; Zhang Y
Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
[TBL] [Abstract][Full Text] [Related]
17. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
Hong M; Han DH; Hong J; Kim DJ; Suk KT
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Barrier Breakdown and Mucosal Microbiota Disturbance in Neuromyelitis Optical Spectrum Disorders.
Cui C; Tan S; Tao L; Gong J; Chang Y; Wang Y; Fan P; He D; Ruan Y; Qiu W
Front Immunol; 2020; 11():2101. PubMed ID: 32983166
[TBL] [Abstract][Full Text] [Related]
19. Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis.
Cayres LCF; de Salis LVV; Rodrigues GSP; Lengert AVH; Biondi APC; Sargentini LDB; Brisotti JL; Gomes E; de Oliveira GLV
Front Immunol; 2021; 12():579140. PubMed ID: 33746942
[TBL] [Abstract][Full Text] [Related]
20. Integrated Analyses of the Gut Microbiota, Intestinal Permeability, and Serum Metabolome Phenotype in Rats with Alcohol Withdrawal Syndrome.
Yang F; Wei J; Shen M; Ding Y; Lu Y; Ishaq HM; Li D; Yan D; Wang Q; Zhang R
Appl Environ Microbiol; 2021 Aug; 87(18):e0083421. PubMed ID: 34190609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
